Retrometabolic approach for designing personalized anti- cancer drug molecules for controlling breast cancer resulted by BRCA1 mutations

Comprehensive strategy for the design of precision drugs and identification of genetic signature behind proneness of the disease-a pharmacogenomic approach.

Comprehensive strategy for the design of precision drugs and identification of genetic signature behind proneness of the disease—a pharmacogenomic approach

Pages